Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1978 Sep;64(1):153–157. doi: 10.1111/j.1476-5381.1978.tb08652.x

The role of beta1- and beta2-adrenoceptors in the inhibition of gastric acid secretion in the dog.

M J Daly, J M Long, R Stables
PMCID: PMC1668263  PMID: 212150

Abstract

1. Characterization of the beta-adrenoceptors mediating inhibition of gastric acid secretion in the conscious Heidenhain pouch dog has been investigated by determination of the effects of propranolol, (+)-propranolol, practolol and H35/25 on salbutamol and isoprenaline-induced inhibition of gastric acid secretion. 2. The gastric antisecretory effect of salbutamol was significantly blocked by propranolol and H35/25 but not by practolol or (+)-propranolol. The effect of isoprenaline was significantly blocked by propranolol and practolol but not by H35/25 or (+)-propranolol. 3. It is concluded that both beta1- and beta2-adrenoceptors can mediate inhibition of pentagastrin-induced gastric secretion in conscious dogs with a Heidenhain pouch. Salbutamol exerts its antisecretory effect through beta2-adrenoceptors, whereas isoprenaline mediates its effects primarily through beta1-adrenoceptors. 4. The results are discussed with regard to the sub-classification of beta-adrenoceptors and to the possible role of adrenoceptors in the physiological control of gastric secretion. 5. In this study it is concluded that the tachycardia induced by isoprenaline or salbutamol is mediated primarily through reflexes activated by beta2-adrenoceptor mediated vasodilatation.

Full text

PDF
153

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ablad B., Borg K. O., Carlsson E., EK L., Johnson G., Malmfors T., Regårdh C. G. A survey of the pharmacological properties of metoprolol in animals and man. Acta Pharmacol Toxicol (Copenh) 1975;36(Suppl 5):7–23. doi: 10.1111/j.1600-0773.1975.tb03318.x. [DOI] [PubMed] [Google Scholar]
  2. Arnold A. Differentiation of receptors activated by catecholamines. 3. Farmaco Sci. 1972 Jan;27(1):79–100. [PubMed] [Google Scholar]
  3. Cullum V. A., Farmer J. B., Jack D., Levy G. P. Salbutamol: a new, selective beta-adrenoceptive receptor stimulant. Br J Pharmacol. 1969 Jan;35(1):141–151. doi: 10.1111/j.1476-5381.1969.tb07975.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Curwain B. P., Holton P. The effects of isoprenaline and noradrenaline on pentagastrin-stimulated gastric acid secretion and mucosal blood flow in the dog. Br J Pharmacol. 1972 Oct;46(2):225–233. doi: 10.1111/j.1476-5381.1972.tb06867.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Daly M. J., Farmer J. B., Levy G. P. Comparison of the bronchodilator and cardiovascular actions of salbutamol, isoprenaline and orciprenaline in guinea-pigs and dogs. Br J Pharmacol. 1971 Nov;43(3):624–638. doi: 10.1111/j.1476-5381.1971.tb07192.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Daly M. J., Flook J. J., Levy G. P. The selectivity of beta-adrenoceptor antagonists on cardiovascular and bronchodilator responses to isoprenaline in the anaesthetized dog. Br J Pharmacol. 1975 Feb;53(2):173–181. doi: 10.1111/j.1476-5381.1975.tb07347.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Daly M. J., Long J. M., Stables R. Classification of the beta-adrenoceptors that mediate inhibition of pentagastrin-induced gastric acid secretion in the dog [proceedings]. Br J Pharmacol. 1977 Nov;61(3):462P–462P. [PMC free article] [PubMed] [Google Scholar]
  8. Daly M. J., Stables R. The effect of (-)-isoprenaline and (+/-)-salbutamol on pepsinogen and acid secretion in the dog. Br J Pharmacol. 1977 Feb;59(2):323–325. doi: 10.1111/j.1476-5381.1977.tb07495.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dunlop D., Shanks R. G. Selective blockade of adrenoceptive beta receptors in the heart. Br J Pharmacol Chemother. 1968 Jan;32(1):201–218. doi: 10.1111/j.1476-5381.1968.tb00444.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ekue J. M., Shanks R. G., Zaidi S. A. Comparison of the effects of isoprenaline, orciprenaline, salbutamol and isoetharine on the cardiovascular system of anaesthetized dogs. Br J Pharmacol. 1971 Sep;43(1):23–31. doi: 10.1111/j.1476-5381.1971.tb07153.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. HARRIES E. H. The effect of noradrenaline on the gastric secretory response to histamine in the dog. J Physiol. 1956 Sep 27;133(3):498–505. doi: 10.1113/jphysiol.1956.sp005604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Howe R., Shanks R. G. Optical isomers of propranolol. Nature. 1966 Jun 25;210(5043):1336–1338. doi: 10.1038/2101336a0. [DOI] [PubMed] [Google Scholar]
  13. Lands A. M., Arnold A., McAuliff J. P., Luduena F. P., Brown T. G., Jr Differentiation of receptor systems activated by sympathomimetic amines. Nature. 1967 May 6;214(5088):597–598. doi: 10.1038/214597a0. [DOI] [PubMed] [Google Scholar]
  14. Levy B. A comparison of the adrenergic receptor blocking properties of 1-(4'-methylphenyl)-2-isopropylamino-propanol-HCl and propranolol. J Pharmacol Exp Ther. 1967 Jun;156(3):452–462. [PubMed] [Google Scholar]
  15. Paton W. D., Vizi E. S. The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip. Br J Pharmacol. 1969 Jan;35(1):10–28. doi: 10.1111/j.1476-5381.1969.tb07964.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sanders D. J. A review: the agents and actions of sympathetic nerve and catecholamine inhibition of gastric mucosal function. Agents Actions. 1976 Jul;6(4):385–388. doi: 10.1007/BF01973207. [DOI] [PubMed] [Google Scholar]
  17. Shanks R. G. The effect of propranolol on the cardiovascular responses to isoprenaline, adrenaline and noradrenaline in the anaesthetized dog. Br J Pharmacol Chemother. 1966 Feb;26(2):322–333. doi: 10.1111/j.1476-5381.1966.tb01911.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES